Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma

Hans A. SchlößerDepartment of General, Visceral and Cancer Surgery, University of Cologne, Germany;Cologne Interventional Immunology, University of Cologne, Germany;Gastrointestinal Cancer Group Cologne, University of Cologne, GermanyCorrespondence[email protected]

Uta DrebberInstitute of Pathology, University of Cologne, Germany

Michael KlothGastrointestinal Cancer Group Cologne, University of Cologne, Germany;Institute of Pathology, University of Cologne, Germany

Martin ThelenCologne Interventional Immunology, University of Cologne, Germany

Sacha I. RothschildCologne Interventional Immunology, University of Cologne, Germany;Department of Internal Medicine I, University of Cologne, Germany;Department of Internal Medicine, Medical Oncology, University Hospital Basel, Switzerland

Simon HaaseDepartment of General, Visceral and Cancer Surgery, University of Cologne, Germany

Maria Garcia-MarquezCologne Interventional Immunology, University of Cologne, Germany;Department of Internal Medicine I, University of Cologne, Germany

Kerstin WennholdCologne Interventional Immunology, University of Cologne, Germany;Department of Internal Medicine I, University of Cologne, Germany

Felix BerlthDepartment of General, Visceral and Cancer Surgery, University of Cologne, Germany

Alexander UrbanskiDepartment of General, Visceral and Cancer Surgery, University of Cologne, Germany

Hakan AlakusDepartment of General, Visceral and Cancer Surgery, University of Cologne, Germany;Gastrointestinal Cancer Group Cologne, University of Cologne, Germany

Astrid SchaussCluster of Excellence in Aging-Associated Disease, Core Facility Imaging, University of Cologne, Germany

Alexander Shimabukuro-VornhagenCologne Interventional Immunology, University of Cologne, Germany;Department of Internal Medicine I, University of Cologne, Germany

Sebastian TheurichCologne Interventional Immunology, University of Cologne, Germany;Department of Internal Medicine I, University of Cologne, Germany;Max-Planck-Institute for Metabolism Research, Cologne, Germany

Ute Warnecke-EbertzDepartment of General, Visceral and Cancer Surgery, University of Cologne, Germany

Dirk L. StippelDepartment of General, Visceral and Cancer Surgery, University of Cologne, Germany

Alfred ZippeliusDepartment of Internal Medicine, Medical Oncology, University Hospital Basel, Switzerland

Reinhard BüttnerInstitute of Pathology, University of Cologne, Germany

Michael HallekDepartment of Internal Medicine I, University of Cologne, Germany

Arnulf H. HölscherDepartment of General, Visceral and Cancer Surgery, University of Cologne, Germany

Thomas ZanderGastrointestinal Cancer Group Cologne, University of Cologne, Germany;Department of Internal Medicine I, University of Cologne, GermanyCorrespondence[email protected]

Stefan P. MönigDepartment of General, Visceral and Cancer Surgery, University of Cologne, Germany;Gastrointestinal Cancer Group Cologne, University of Cologne, Germany

Michael von Bergwelt-BaildonCologne Interventional Immunology, University of Cologne, Germany;Department of Internal Medicine I, University of Cologne, Germany

show all

Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma

Articles from other publishers (34)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma

Citations (38)

Read on this site (4)

Articles from other publishers (34)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date